menu
    • menu
    [{"orgOrder":0,"company":"Symrise","sponsor":"Ceapro","pharmaFlowCategory":"D","therapeuticArea":"Dermatology","country":"","productType":"Small molecule","year":"2022","type":"Agreement","leadProduct":"Avenanthramides","moa":"","graph1":"Dermatology","graph2":"Approved","graph3":"Symrise","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Topical Cream","sponsorNew":"Symrise \/ Symrise","highestDevelopmentStatusID":"12","companyTruncated":"Symrise \/ Symrise"}]

    Find Clinical Drug Pipeline Developments & Deals by Symrise

    Menu

    Symrise

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Symrise

                            Germany arrow
                            CPhI India 2024
                            Not Confirmed

                            Symrise

                            Germany arrow
                            CPhI India 2024
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Oat Beta Glucan,Avenanthramides

                            Therapeutic Area : Dermatology

                            Study Phase : Approved

                            Recipient : Ceapro

                            Deal Size : Undisclosed

                            Deal Type : Agreement

                            DEALS_DEV arrow-down

                            Ceapro Signs Exclusive Long-Term Supply and Distribution Agreement with Leading Global Provider of Active Ingr...

                            Details : Under the agreement, Symrise is guaranteed to purchase minimum annual volumes of Ceapro’s high value active ingredients. These skills merge in the fields of active ingredients, biopharmaceuticals and drug-delivery solutions.

                            Brand Name : Juvente

                            Molecule Type : Small molecule

                            Upfront Cash : Undisclosed

                            March 10, 2022

                            Lead Product(s) : Oat Beta Glucan,Avenanthramides

                            Therapeutic Area : Dermatology

                            Highest Development Status : Approved

                            Recipient : Ceapro

                            Deal Size : Undisclosed

                            Deal Type : Agreement

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth